Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
CardiovascularORALStandard

FLUVASTATIN SODIUM

FLUVASTATIN SODIUM

Standard Dose
EQ 20MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FLUVASTATIN SODIUM is listed in Drugs@FDA under application 090595 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FLUVASTATIN SODIUM Form and strength CAPSULE;ORAL - EQ 20MG BASE Sponsor MYLAN PHARMS INC Submission history Latest submission status date: 2020-09-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLUVASTATIN SODIUM is listed in Drugs@FDA under application 090595 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FLUVASTATIN SODIUM Form and strength CAPSULE;ORAL - EQ 20MG BASE Sponsor MYLAN PHARMS INC Submission history Latest submission status date: 2020-09-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
FLUVASTATIN SODIUM (FLUVASTATIN SODIUM) | Drug Monograph | MedicHelpline